Palliative surgery in patients with unresectable colorectal liver metastases: A propensity score matching analysis

Journal of Surgical Oncology

Volumn 109, Issue 3, 2014, Pages 239-244

  Yoon, Yong Sik ^a   Kim, Chan Wook ^a   Lim, Seok Byung ^a   Yu, Chang Sik ^a   Kim, So Yeon ^a   Kim, Tae Won ^a   Kim, Min Ju ^a   Kim, Jin Cheon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Colorectal adenocarcinomas; propensity score matching; surgical treatment; survival

Indexed keywords

CAPECITABINE; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURGERY; COLORECTAL LIVER METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL; UNSPECIFIED SIDE EFFECT;

COLORECTAL ADENOCARCINOMAS; PROPENSITY SCORE MATCHING; SURGICAL TREATMENT; SURVIVAL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROPENSITY SCORE; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84893708929     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23480     Document Type: Article

References (30)

1. Cook AD, Single R, McCahill LE:, Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: An analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005; 12: 637-645.
2. Damjanov N, Weiss J, Haller DG:, Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 2009; 14: 963-969.
3. Gallagher DJ, Kemeny N:, Metastatic colorectal cancer: From improved survival to potential cure. Oncology 2010; 78: 237-248.
4. Benoist S, Pautrat K, Mitry E, et al.: Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92: 1155-1160.
5. Tebbutt NC, Norman AR, Cunningham D, et al.: Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003; 52: 568-573.
6. Gruenberger B, Tamandl D, Schueller J, et al.: Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 2008; 26: 1830-1835.
7. Reddy SK, Tsung A, Marsh JW, et al.: Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases ? J Surg Oncol 2012; 105: 55-59.
8. Mik M, Dziki L, Galbfach P, et al.: Resection of the primary tumour or other palliative procedures in incurable stage IV colorectal cancer patients ? Colorectal Dis 2010; 12: e61-e67.
9. Law WL, Chan WF, Lee YM, et al.: Non-curative surgery for colorectal cancer: Critical appraisal of outcomes. Int J Colorectal Dis 2004; 19: 197-202.
10. Yun HR, Lee WY, Lee WS, et al.: The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis 2007; 22: 1301-1310.et al.
11. Purkiss SF:, The assessment of percentage hepatic replacement using planimetry of computerized tomographic images. Surg Oncol 1996; 5: 231-236.
12. Galizia G, Lieto E, Orditura M, et al.: First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008; 143: 352-358; discussion 358.
13. Kleespies A, Fuessl KE, Seeliger H, et al.: Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis 2009; 24: 1097-1109.
14. Kobayashi H, Kotake K, Sugihara K:, Prognostic scoring system for stage IV colorectal cancer: Is the AJCC sub-classification of stage IV colorectal cancer appropriate ? Int J Clin Oncol 2013; 18: 696-703.
15. Konyalian VR, Rosing DK, Haukoos JS, et al.: The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis 2007; 9: 430-437.
16. Stillwell AP, Buettner PG, Siu SK, et al.: Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer. Dis Colon Rectum 2011; 54: 535-544.
17. Stillwell AP, Buettner PG, Ho YH:, Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 2010; 34: 797-807.
18. Karoui M, Roudot-Thoraval F, Mesli F, et al.: Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: Results of a multicentric study. Dis Colon Rectum 2011; 54: 930-938.
19. Danna EA, Sinha P, Gilbert M, et al.: Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 2004; 64: 2205-2211.
20. Wang HS, Lin JK, Mou CY, et al.: Long-term prognosis of patients with obstructing carcinoma of the right colon. Am J Surg 2004; 187: 497-500.
21. Winner M, Mooney SJ, Hershman DL, et al.: Management and outcomes of bowel obstruction in patients with stage IV colon cancer: A population-based cohort study. Dis Colon Rectum 2013; 56: 834-843.
22. Wasserberg N, Kaufman HS:, Palliation of colorectal cancer. Surg Oncol 2007; 16: 299-310.
23. Platell C, Ng S, O'Bichere A, et al.: Changing management and survival in patients with stage IV colorectal cancer. Dis Colon Rectum 2011; 54: 214-219.
24. Makela J, Haukipuro K, Laitinen S, Kairaluoma MI:, Palliative operations for colorectal cancer. Dis Colon Rectum 1990; 33: 846-850.
25. Yamamura T, Tsukikawa S, Akaishi O, et al.: Multivariate analysis of the prognostic factors of patients with unresectable synchronous liver metastases from colorectal cancer. Dis Colon Rectum 1997; 40: 1425-1429.
26. Sakamoto Y, Fujita S, Akasu T, et al.: Is surgical resection justified for stage IV colorectal cancer patients having bilobar hepatic metastases?-An analysis of survival of 77 patients undergoing hepatectomy. J Surg Oncol 2010; 102: 784-788.
27. Chafai N, Chan CL, Bokey EL, et al.: What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer ? Colorectal Dis 2005; 7: 176-181.
28. Liu SK, Church JM, Lavery IC, et al.: Operation in patients with incurable colon cancer-Is it worthwhile ? Dis Colon Rectum 1997; 40: 11-14.
29. Stuart EA:, Matching methods for causal inference: A review and a look forward. Stat Sci 2010; 25: 1-21.
30. Suarez D, Haro JM, Novick D, et al.: Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies. J Clin Epidemiol 2008; 61: 525-530.